Sleep Disturbances in Smith-Magenis SyndromeSleepRare diseaseChildren's health
What this study is
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
What's being tested
- Data collection of sleep disturbances in individuals with SMS
Intervention · OTHER
Data related to Smith-Magenis syndrome and sleep disturbances are collected through a web or phone survey
Study details
- Official title
- Development of Clinical Database of Individuals With Smith-Magenis Syndrome
- Sponsor
- Vanda Pharmaceuticals
- Conditions
- Sleep Disturbances in Smith-Magenis Syndrome
- Enrolling
- 1,000 people
- Starts
- 2016-01
- Est. completion
- 2030-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 3 Years – 65 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Parent or legal guardian of individual with Smith-Magenis Syndrome
You can't join if
- Not legal guardian of individual with SMS
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openVanda Pharmaceuticals
Washington D.C., District of Columbia, United States
- Vanda Pharmaceuticals · Contact202-734-3400
Recruiting
Study team
Sponsor
Vanda Pharmaceuticals
Study ID Pro00015678
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.